Introduction: A cross-border industrial exchange has taken place. European biomanufacturing representatives visited Viablife to witness the Chinese synthetic-biology firm’s AI-enabled smart manufacturing strengths, and jointly map new prospects for China-EU green bio-industry cooperation.

Recently, the French BioManufacturing industry delegation, organized by BIOKET, completed its China industry tour. As a key destination on this itinerary, Viablife hosted multi-national industry guests for site visits and in-depth roundtable discussions. Delegates from biotechnology firms, industrial clusters and research institutes across France, Germany, Belgium and Portugal gathered to exchange views on cutting-edge synthetic-biology R&D, industrial roll-out and global industrial collaboration, identifying two-way cooperation points and new growth potential for China-EU industries.

Gathering European Industrial Leaders to Build a China-EU Smart Biomanufacturing Bridge

This delegation brings together top-tier players from Europe’s biomanufacturing sector, including representatives from 30 global leading enterprises such as BASF and Clariant. Their businesses cover the full value chain: biomanufacturing, agri-food, renewable feedstocks and green chemistry. Representing Europe’s advanced biomanufacturing landscape, the group acts as a key liaison linking Chinese and European markets and facilitating cross-border industrial collaboration.

Synthetic-Biology Expertise: An Integrated Innovation Ecosystem

During the tour, Viablife’s Head of International Business presented the company’s milestones, global footprint and R&D infrastructure, with special focus on its AI-driven Viablife Biolego® platform. Leveraging proprietary biosynthetic technology, extensive high-yield strain collections, a specialized biocatalyst library and the internationally collaborative Honghu Laboratory, Viablife demonstrated its core innovation and industrialization capabilities in AI-driven biomanufacturing.

Viablife focuses on two core verticals: bio-health and bio-based new materials. It operates a full-stack platform spanning R&D, production and end-use applications, with multiple world-first technologies and products. Built on synthetic biology and AI, the firm follows a three-pronged innovation framework. It integrates biotechnology, digital technologies, and AI to advance intelligent biomanufacturing, including genetic, enzyme, metabolic and fermentation engineering, big data, cloud computing, Industry 4.0, and deep learning.

Viablife also runs its self-developed large-scale smart manufacturing hub — Viablife Biolego® Factory, featuring low-carbon digital production lines for stable, high-quality raw-material supply. For strategic emerging industries, Viablife connects the complete value chain from scientific innovation and advanced manufacturing to commercialization, advancing the industry’s green, digital-intelligent and global transformation.

Charting New Industrial Horizons: Unlocking European Market Access for Chinese Smart Biomanufacturing

At the roundtable, participants discussed biomanufacturing trends in China and Europe and explored cooperation pathways for Chinese smart-biomanufacturing solutions entering the European market.

Delegates highly commended Viablife’s platform innovation and proven industrial capacity. The Viablife Biolego® platform’s performance in accelerating R&D and boosting production efficiency became a central topic. They noted that Viablife’s products align well with global biomanufacturing upgrade demands, featuring strong practicality and commercial maturity that match Europe’s ongoing automation and digital-transformation agenda.

In open-floor sessions, overseas representatives held active exchanges. They reviewed respective competitive edges for joint technology development, market complementarity and full-value-chain cooperation, and shared hands-on experience for cross-border projects and local implementation. Multiple companies held one-on-one talks with the Viablife team to explore diverse bilateral partnership possibilities.

This visit creates an important channel for Viablife to engage premium European industrial resources and benchmark against international technical standards, laying solid groundwork for further European-market expansion and cross-border technical partnerships.

Going forward, Viablife will uphold its corporate mission “To Create a Better Future through Innovations”. It will keep investing in AI-led original innovation, translating lab-scale synthetic-biology breakthroughs into large-scale green advanced manufacturing. By delivering cutting-edge technologies and professional services to worldwide clients, Viablife will support China’s synthetic-biology industry as it moves toward high-end, smart, green and global development.